JezK
Edit File: 1648773068.M280370P232802.mocha3025.mochahost.com,S=23710,W=24128:2,S
Return-Path: <staniczais@who.int> Received: from mocha3025.mochahost.com by mocha3025.mochahost.com with LMTP id 6CIPDsxHRmJijQMAaMJ/gg (envelope-from <staniczais@who.int>); Thu, 31 Mar 2022 20:31:08 -0400 Return-path: <staniczais@who.int> Envelope-to: takal@jack.ngo, ahmad@jack.ngo, obaid.shahzad@jack.ngo Delivery-date: Thu, 31 Mar 2022 20:31:08 -0400 Received: from mail-vi1eur05on2066.outbound.protection.outlook.com ([40.107.21.66]:22113 helo=EUR05-VI1-obe.outbound.protection.outlook.com) by mocha3025.mochahost.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384 (Exim 4.94.2) (envelope-from <staniczais@who.int>) id 1na5C1-000xVN-3B; Thu, 31 Mar 2022 20:31:08 -0400 ARC-Seal: i=1; a=rsa-sha256; s=arcselector9901; d=microsoft.com; cv=none; b=WUeit7Y5v8zQQOGGhNQZqq8msDZnQU1eQ7dO6r0kuyM7R2Xbdv/7gr4IAvMtIQPdhc8DqXtw1zFGmnI+qg4tTgqyUqVVo9iKmelCwn2KwJUtFK4sVnEt6EPJnHea+P/FRibp2oH5sJztrzwx7/plOZUpvK3uGEWXYRv+GklK2FN3eNChtq/lqZkiSZZfhhyFd15mPYktpSVsxZ1V5/L+PfQ+KtEMUI1ptFAOlDztZeG0+1bqIJ9bAU0E61AJs5Ch2qbkILx31jBbevZ0VVBVLhbbet8/Ipi46Bu+rh510lhLA4j0Dy0nstWKJGe0KIPLHGFlwRFcLF6IzPTWQLjsDQ== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector9901; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=GqC+TRdEZ3N/PVaCXqDbuPnQwwOrI6KlPMGBc8nvxAA=; b=lSEsjulAitF3ksM4TfvqEMjQPH1oI2cul1rhUl33nI6MIEVMWXbnZLlkgJCqjGrymuJv4Bud9M+BWYtTj2tLmy2sDp33uGsldA9ukRi+iUC48mUl6qLO3KBcp1vdRbHkf8Mmb0CyU3muEeqIR87MnYlX0I+ZOBmjytFmdow3vksC+eGs5ZG2krgtywaJmQ00BqVnQvBg0IQ9K6bZ2BcknG6t9un2OMJjd+uMkrUB4LMP8jB31qaOacfq0XdpX5P1VFmFYLa5895AN4mybBF4StxYDmtR0LsLR4FOd2KZh4DMu4oXYQwLFYJJjrOXyKVSCQs2ABeQJ8CzOJnp6DMbCg== ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=who.int; dmarc=pass action=none header.from=who.int; dkim=pass header.d=who.int; arc=none DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=who.int; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=GqC+TRdEZ3N/PVaCXqDbuPnQwwOrI6KlPMGBc8nvxAA=; b=ZIzirHK5p3CufJE2naZ8DuuwurvKnEHMGQ6wOMKalRSpiPByd3HwOKctbz3PmQVylG+0z8Oa054Y0VQv+J1av7PBECo/8D2hob5KPs4XfAwRwbnn0i45DKhRlpTEaBYClqlEGYbmn8ERVtEhLPLAr5e+/VZTnQriE1H+8i2drQk= Received: from AS8PR01MB7704.eurprd01.prod.exchangelabs.com (2603:10a6:20b:2a6::7) by AM6PR01MB5464.eurprd01.prod.exchangelabs.com (2603:10a6:20b:f2::16) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.5123.23; Fri, 1 Apr 2022 00:29:45 +0000 Received: from AS8PR01MB7704.eurprd01.prod.exchangelabs.com ([fe80::d878:a169:6e8a:f3b9]) by AS8PR01MB7704.eurprd01.prod.exchangelabs.com ([fe80::d878:a169:6e8a:f3b9%9]) with mapi id 15.20.5102.023; Fri, 1 Apr 2022 00:29:45 +0000 From: "STANICZAI, Shah Mansoor" <staniczais@who.int> To: Fekadu Tafa Lemma <tafa@un.org> CC: "Sardar Wali Takal [JACK]" <takal@jack.ngo>, "Noor Ahmad [JACK]" <ahmad@jack.ngo>, "obaid.shahzad@jack.ngo" <obaid.shahzad@jack.ngo> Subject: RE: [EXT] AFG-21/3481/SA1/H/NGO/21380 Thread-Topic: [EXT] AFG-21/3481/SA1/H/NGO/21380 Thread-Index: AdhE6KM5xWiLCJ7sQwW86cX1Yc+flAAdlw9g Date: Fri, 1 Apr 2022 00:29:44 +0000 Message-ID: <AS8PR01MB7704847246BA0B9843861408D4E09@AS8PR01MB7704.eurprd01.prod.exchangelabs.com> References: <DBAPR07MB6837737FD346D9D228E359C4A7E19@DBAPR07MB6837.eurprd07.prod.outlook.com> In-Reply-To: <DBAPR07MB6837737FD346D9D228E359C4A7E19@DBAPR07MB6837.eurprd07.prod.outlook.com> Accept-Language: en-US Content-Language: en-US X-MS-Has-Attach: yes X-MS-TNEF-Correlator: authentication-results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=who.int; x-ms-publictraffictype: Email x-ms-office365-filtering-correlation-id: 95461024-619e-4c09-c74e-08da1376b892 x-ms-traffictypediagnostic: AM6PR01MB5464:EE_ x-microsoft-antispam-prvs: <AM6PR01MB54644B43ECA3A6471531919ED4E09@AM6PR01MB5464.eurprd01.prod.exchangelabs.com> x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 x-microsoft-antispam: BCL:0; x-microsoft-antispam-message-info: 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 x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:AS8PR01MB7704.eurprd01.prod.exchangelabs.com;PTR:;CAT:NONE;SFS:(13230001)(4636009)(366004)(186003)(8936002)(2906002)(86362001)(26005)(52536014)(83380400001)(122000001)(38070700005)(38100700002)(166002)(99936003)(5660300002)(9686003)(33656002)(53546011)(54906003)(6916009)(316002)(296002)(66946007)(71200400001)(4326008)(966005)(508600001)(7696005)(6506007)(66556008)(64756008)(66476007)(55016003)(76116006)(66446008)(8676002);DIR:OUT;SFP:1101; x-ms-exchange-antispam-messagedata-chunkcount: 1 x-ms-exchange-antispam-messagedata-0: =?us-ascii?Q?UoL8tfPVq6bzVQbkaeeoMAsDGnWIRXcZDE6JbwPXPPEw3HcZ+kqSetwD5Mw9?= =?us-ascii?Q?2tjnL6JANHO1YulJvq+FDfZL38gFJOT7Y6y4nIGYIcQwXIZM0JaIulHQ9rnm?= =?us-ascii?Q?G0fCWv77GfymQwtme5jPqkV2kGEICtp2sZPh7qQlqxu1Wg2ClwgcJ4inITP8?= =?us-ascii?Q?XwjUFCZZtnd5ahOYOPr/3DwB5AiEOqmsanJ7alKdTrt7Q1c9cI++/O9NgJFJ?= =?us-ascii?Q?S+JiG5skfDZAeKQLFPQRqzAw2UCwDXDM9KiJ5Lanf1dNNZ74ZXqNnbGlrBsZ?= =?us-ascii?Q?Mj9RNgZ7NYj2vVVIuM0s/51hFuM34Roly6SgA7REfvPA1sBxrQyusqaAwUyW?= =?us-ascii?Q?0lhN7ef62YcE5Mmc/7GjuQSUdeATPMKR4k3bV80NmJzica+oOm7hNTLnkOMp?= =?us-ascii?Q?OpauxnIe+A7Fm/XIqMJ0fhOYgK41jUMEaX3VwG2s/Sf/yB1uNr5rGUHbTzKN?= =?us-ascii?Q?vKtwKpY9wY2ZlovKwwbaa3s2iXjo3+tPlQrgeT/28plPfBHF3zEH7PJt0GiD?= =?us-ascii?Q?q64XAGn/R2dGVd/dEjfL1FqrkGKtzTNw7YA2AH9HCGBhjjgozEkOTRo33rP+?= =?us-ascii?Q?5cIDaX+QBhJt9suU6fUK6ECx4gDypeUohpJt+mlJFNoHs8O8gdhlHqKooX9C?= =?us-ascii?Q?7Ih80Y2zxqp37q89gM/NYIqB4z19hqBeYtVZxuF8El9wnsd99ib1g9PEZMi1?= =?us-ascii?Q?WbtdAmtDs8Yz4wwFQ4AF4d/aSCLCJGHQs7Fdvy7C9CDOI3IB4zaQvhr5Y6x6?= =?us-ascii?Q?Nx60AbT94EcTaRIjoR8ix7cAZMkGrMHeZlMwARQ+/iyEzxXnEz41DhQPdo4A?= =?us-ascii?Q?dDihawiE70awCTQXW45pb+/0XoqGlYiG/xuluYFqZxugN7AcrLLOXHoNeswv?= =?us-ascii?Q?flZ6Rjxwrozm2TFJyZ1BlBzQNvacnmsEIdXAzEIAp0QatHRRrUzmGCPAEW+T?= =?us-ascii?Q?6/W3jJo2anjk9TKY5LygALjdl7iXlgYUAmzGrPBrtXIaxMP6NGuT+Is1hAH8?= =?us-ascii?Q?1rCn57w0qaR17Yku0i/avVOPN+DTKln5ydfe3RQbc5UzuFDlhdbJn7CTC3eY?= =?us-ascii?Q?ojdySZ3jX2Rmj1dH2EoTvOX49WfFvkqT7LVR4415YRz9sZ6Zt7da0wpvMpOC?= =?us-ascii?Q?W4N51NkRYfsdbASKDcf91PnbgJzbBKq+7u7ITof3Lu5dG1NACT4a7mGpz5Fb?= =?us-ascii?Q?KDsknWim2a5X7tP/x85CKhirUMaCs8xi+/ckHviKD7Z3PJJ1wCIo4JKkdTWd?= =?us-ascii?Q?TYYeqYlclfzJFhUK/NIbfShgvReL/gZwSxtZ7O7bjK43YppSTlYPZYQwGHNb?= =?us-ascii?Q?vjxhmQJJvhGcIO//A3zTSoJWas2yj0krmuxtcItXzG/AH2NEgqP5pg7bua17?= =?us-ascii?Q?UGmLN1oHpGIcp6L0WVIJx/BCAfT6cqcll6mreJdCStEQq/JU8KcRF8ILVkvb?= =?us-ascii?Q?BYnvHZVssGwsCjgbfysXATVHQHZujyp+YELFsonQbKXs0mUJ8rd8Pt8e7NFR?= =?us-ascii?Q?NQh/GOV5rxnqkasymVAocIxSYE9iOv659LADcpTe8osxsUlTu8WbFbpXbcpo?= =?us-ascii?Q?fSn2zYPGMH6d8Pb8bgD2DEU+ZAc8Bw7OZKZ4thWmDEMhpVqc3XvqHW6og2xM?= =?us-ascii?Q?7/E+/RLdl+y6BAcqkPa2kysDZm78fTe9BoeXDwwcwQ1JFxnGOmeLXReFXa1Z?= =?us-ascii?Q?Ku4I8eb1JDJ8SHwUSblD1PszE2gWY2p+IEM1PIlJ+HYMcdgVhMxVGbOU3UTn?= =?us-ascii?Q?qj/NtbLDrg=3D=3D?= Content-Type: multipart/related; boundary="_004_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_"; type="multipart/alternative" MIME-Version: 1.0 X-OriginatorOrg: who.int X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: AS8PR01MB7704.eurprd01.prod.exchangelabs.com X-MS-Exchange-CrossTenant-Network-Message-Id: 95461024-619e-4c09-c74e-08da1376b892 X-MS-Exchange-CrossTenant-originalarrivaltime: 01 Apr 2022 00:29:44.9104 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: f610c0b7-bd24-4b39-810b-3dc280afb590 X-MS-Exchange-CrossTenant-mailboxtype: HOSTED X-MS-Exchange-CrossTenant-userprincipalname: MRsqWbicxYYk2P5hBCKkEkRcO0JnJay0hZDz+Y3YRqM0Om4HveWGS9k740p6J8ELMO9hvBfQlzq/cwBc1l80eQ== X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM6PR01MB5464 --_004_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_ Content-Type: multipart/alternative; boundary="_000_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_" --_000_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_ Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: quoted-printable Dear Fekadu, This is to confirm the partner did not elaborate properly treatment of acut= e malnutrition in under five children (OPD-SAM and OPD-MAM) and PLW in thei= r proposal. They did consider recruitment of nutrition nurse, and staff training on nut= rition SOP that capacitate staff on the management of acute malnutrition. Best regards, Mansoor Staniczai, MD, MPH Health Cluster Coordination Team World Health Organization (WHO) | Kabul, Afghanistan | Mobile Number (Incl.= WhatsApp): +93 794 629 097 | Email: staniczais@who.int<mailto:staniczais@w= ho.int> | Skype: mstaniczai | Web: www.who.int<https://www.who.int/> [cid:image001.png@01D7C667.3A162560] From: Fekadu Tafa Lemma [mailto:tafa@un.org] Sent: Thursday, March 31, 2022 2:54 PM To: STANICZAI, Shah Mansoor <staniczais@who.int> Cc: Sardar Wali Takal [JACK] <takal@jack.ngo>; Noor Ahmad [JACK] <ahmad@jac= k.ngo>; obaid.shahzad@jack.ngo Subject: [EXT] AFG-21/3481/SA1/H/NGO/21380 Dear Dr Mansoor, The JACK project proposal AFG-21/3481/SA1/H/NGO/21380 is now at the final s= tage of grant agreement processing. Before the final endorsement, we're no= w requested to clarify the following: Jack Health: ' It's not clear if screening for malnutrition / growth monit= oring is followed by treatment or only to referral. And if it's the second = that should be amended." Grateful if you please clarify this as soon as po= ssible for the grant agreement to proceed. Fekadu Tafa Lemma Afghanistan Humanitarian Fund (AHF)| HAO (Focal Point - Program) United Nations Office for the Coordination of Humanitarian Affairs (OCHA) K= abul, Afghanistan Mobile: +93 79 300 1144 | WhatsApp: https://wa.me/+251911166900 E-mail: taf= a@un.org<mailto:tafa@un.org>; | Skype: fekadu.tafa ahf-afg@un.org<mailto:ahf-afg@un.org> | www.unocha.org/ahf<http://www.unoch= a.org/ahf> --_000_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_ Content-Type: text/html; charset="us-ascii" Content-Transfer-Encoding: quoted-printable <html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr= osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" = xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http:= //www.w3.org/TR/REC-html40"> <head> <meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii"= > <meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)"> <!--[if !mso]><style>v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);} </style><![endif]--><style><!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {margin:0in; margin-bottom:.0001pt; font-size:11.0pt; font-family:"Calibri",sans-serif;} a:link, span.MsoHyperlink {mso-style-priority:99; color:#0563C1; text-decoration:underline;} a:visited, span.MsoHyperlinkFollowed {mso-style-priority:99; color:#954F72; text-decoration:underline;} p.msonormal0, li.msonormal0, div.msonormal0 {mso-style-name:msonormal; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; font-size:12.0pt; font-family:"Times New Roman",serif;} span.EmailStyle18 {mso-style-type:personal; font-family:"Calibri",sans-serif; color:windowtext;} span.EmailStyle19 {mso-style-type:personal-reply; font-family:"Arial",sans-serif; color:windowtext; font-weight:normal; font-style:normal;} .MsoChpDefault {mso-style-type:export-only; font-size:10.0pt;} @page WordSection1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in;} div.WordSection1 {page:WordSection1;} --></style><!--[if gte mso 9]><xml> <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" /> </xml><![endif]--><!--[if gte mso 9]><xml> <o:shapelayout v:ext=3D"edit"> <o:idmap v:ext=3D"edit" data=3D"1" /> </o:shapelayout></xml><![endif]--> </head> <body lang=3D"EN-US" link=3D"#0563C1" vlink=3D"#954F72"> <div class=3D"WordSection1"> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif">Dear Fekadu,<o:p></o:p></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif">This is to confirm the partner did not elaborate prop= erly treatment of acute malnutrition in under five children (OPD-SAM and OP= D-MAM) and PLW in their proposal. <o:p></o:p></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif"><o:p> </o:p></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif">They did consider recruitment of nutrition nurse, and= staff training on nutrition SOP that capacitate staff on the management of= acute malnutrition. <o:p></o:p></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif"><o:p> </o:p></span></p> <div> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif">Best regards, <o:p></o:p></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif"><o:p> </o:p></span></p> <p class=3D"MsoNormal"><b><span style=3D"font-size:10.0pt;font-family:"= ;Arial",sans-serif">Mansoor Staniczai, MD, MPH <o:p></o:p></span></b></p> <p class=3D"MsoNormal"><b><span style=3D"font-size:10.0pt;font-family:"= ;Arial",sans-serif"><o:p> </o:p></span></b></p> <p class=3D"MsoNormal"><b><span style=3D"font-size:10.0pt;font-family:"= ;Arial",sans-serif">Health Cluster Coordination Team<o:p></o:p></span>= </b></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif;color:black;mso-fareast-language:KO"><o:p> </o:p>= </span></p> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif">World Health Organization (WHO) </span><span style=3D"font-size:10.0pt;font-family:"Arial",sans-s= erif;color:black;mso-fareast-language:KO">| </span><span style=3D"font-size:10.0pt;font-family:"Arial",sans-s= erif">Kabul, Afghanistan </span><span style=3D"font-size:10.0pt;font-family:"Arial",sans-s= erif;color:black;mso-fareast-language:KO">| Mobile Number (Incl. WhatsApp):= +93 794 629 097 | Email: <a href=3D"mailto:staniczais@who.int">stanic= zais@who.int</a> | Skype: mstaniczai |</span><span style=3D"font-size:10.0p= t;font-family:"Arial",sans-serif;color:black"> Web: <a href=3D"https://www.who.int/" title=3D"https://www.who.int">w= ww.who.int</a><o:p></o:p></span></p> <p class=3D"MsoNormal"><b><o:p> </o:p></b></p> <p class=3D"MsoNormal"><b><img border=3D"0" width=3D"139" height=3D"73" id= =3D"Picture_x0020_1" src=3D"cid:image002.jpg@01D84585.4D0D8C10" alt=3D"cid:= image001.png@01D7C667.3A162560"><o:p></o:p></b></p> </div> <p class=3D"MsoNormal"><span style=3D"font-size:10.0pt;font-family:"Ar= ial",sans-serif"><o:p> </o:p></span></p> <div> <div style=3D"border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in = 0in 0in"> <p class=3D"MsoNormal"><b>From:</b> Fekadu Tafa Lemma [mailto:tafa@un.org] = <br> <b>Sent:</b> Thursday, March 31, 2022 2:54 PM<br> <b>To:</b> STANICZAI, Shah Mansoor <staniczais@who.int><br> <b>Cc:</b> Sardar Wali Takal [JACK] <takal@jack.ngo>; Noor Ahmad [JAC= K] <ahmad@jack.ngo>; obaid.shahzad@jack.ngo<br> <b>Subject:</b> [EXT] AFG-21/3481/SA1/H/NGO/21380 <o:p></o:p></p> </div> </div> <p class=3D"MsoNormal"><o:p> </o:p></p> <p class=3D"MsoNormal">Dear Dr Mansoor, <o:p></o:p></p> <p class=3D"MsoNormal">The JACK project proposal AFG-21/3481/SA1/H/NGO/2138= 0 is now at the final stage of grant agreement processing. Before the= final endorsement, we’re now requested to clarify the following: <o:p></o:p></p> <p class=3D"MsoNormal"> Jack Health: ‘ It’s not clear if s= creening for malnutrition / growth monitoring is followed by treatment or o= nly to referral. And if it’s the second that should be amended.”= ; Grateful if you please clarify this as soon as possible for the grant agreement to proceed.<o:p></o:p></p> <p class=3D"MsoNormal"><o:p> </o:p></p> <p class=3D"MsoNormal">Fekadu Tafa Lemma<o:p></o:p></p> <p class=3D"MsoNormal">Afghanistan Humanitarian Fund (AHF)| HAO (Focal Poin= t – Program)<o:p></o:p></p> <p class=3D"MsoNormal">United Nations Office for the Coordination of Humani= tarian Affairs (OCHA) Kabul, Afghanistan <o:p></o:p></p> <p class=3D"MsoNormal">Mobile: +93 79 300 1144 | WhatsApp: <a href=3D"https= ://wa.me/+251911166900"> https://wa.me/+251911166900</a> E-mail: <a href=3D"mailto:tafa@un.org">tafa= @un.org</a>; | Skype: fekadu.tafa<o:p></o:p></p> <p class=3D"MsoNormal"><a href=3D"mailto:ahf-afg@un.org">ahf-afg@un.org</a>= | <a href=3D"http://www.unocha.org/ahf"> www.unocha.org/ahf</a><o:p></o:p></p> <p class=3D"MsoNormal"><o:p> </o:p></p> </div> </body> </html> --_000_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_-- --_004_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_ Content-Type: image/jpeg; name="image002.jpg" Content-Description: image002.jpg Content-Disposition: inline; filename="image002.jpg"; size=3656; creation-date="Fri, 01 Apr 2022 00:29:44 GMT"; modification-date="Fri, 01 Apr 2022 00:29:44 GMT" Content-ID: <image002.jpg@01D84585.4D0D8C10> Content-Transfer-Encoding: base64 /9j/4AAQSkZJRgABAQEAeAB4AAD/2wBDAAoHBwkHBgoJCAkLCwoMDxkQDw4ODx4WFxIZJCAmJSMg IyIoLTkwKCo2KyIjMkQyNjs9QEBAJjBGS0U+Sjk/QD3/2wBDAQsLCw8NDx0QEB09KSMpPT09PT09 PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT3/wAARCABJAIsDASIA AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3 ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3 uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2amvI kS7pHVF9WOBTq8u8ZeP/AAfr+n3egX99fW6+aFkkitzlWRs9/celAHS+NPGzeD5NPlfTp7qynLfa JogcRAYwc9M8ng+lYGs+PL+w1ax8RWTx33hCeNYZTDy0Lk8sw6hh0x+HXFZXh+w1CytXuPBXiWHx BZKuZtKvOGZe4Geh/AfjU1lHpmn79X063ePw/qD/AGPW9KmGPsUh4347AEgH2OR7AHQad4xvV+Is uk6kYTp2oQLPpUsX3XUDPXuSM/l71v8AhfxVZeK7W6nsVkRba4aBllGGyMc47ZzXm2oafNo2gTQM zPdeEdTjntpT95rWQggfqQf92pL2S68O3nxBXSZ2tmMcF/C8fVdxy2Prk0AewUVleGrx7zw1pc1x JvnltI3cseWJUZNatABRRRQAUUUUAFFFFABRRRQAUUUUAc/4y8WReD9IS9ltJ7oySCJEiH8RBxk9 ulcXpk3i3US91Y+CdFsYp2MjG7GHcnkk98n3Fdl4h1ieO8h0vTrMT3smJFaRcog/vc9x+lZhtrUX Plapf32q6h1aC1J2p+AwB+JFdEMO2uaT/V/16nJUxSjJxir2+S9PN+hjXVhElwlxr3h8+H71T+61 jS3DRxt2346D13Aj3FXRbG6v5BqUUYuLtBp+qiIfu7lHU+TcKPr8vtkjsK3raz8ofuLbULNW42yO JY2H+0uTViz0CKFFCKqxJxGgOQi7g20f7IYZHpnFZzhy7M2p1HPdWOI1COSXQtQa5H7640COCY/3 pUlZFP1yTUXimIrF41mX5mNvZ6bHj+OQgZH1+da63VLAWrBnjaSPejtGgyZdjF0jA9WkbP0WsaG1 WSeE3jhrTTLh9Q1KZeVnvW+7Evrsz+iioSbdkaNpK7NLS7VLPxRHG8irFpenRQM5bCg4AHNdgCCA Qcg9xXB3lrcS2iWLjGo6zP586/8APKIdAfp/jXb2aQx2cMduVaFECoVORgcV1YmKSi7+X3f8G5x4 SbcpK3n9/T5KxXu9TW01KyszGzNdlwGB4XaM81HNrKRancWZhYtBbfaC2Rgj0rL8TwzXOt6NFbXB t5maXbKBkr8o7VSgtrm017Uory7N3L/ZpPmFccZ6U4UYOCk97frYipiKkZuKWl7X07XsaVh4pmv5 bcJo94sMzACY4KgHv9Kvavrlvo8lok4J+0ybBg/dHdj7cisDwq/lx2DSa9GyFNosiVyCeg9apaxe Jqms6jvtLm5hjiNrA0Me4I/Ut9c1p9Xg6vLbRev6mf1qcaCk37z9PXodjqOprp0tmjRs5uphCCDj aT3qrrevPozj/iXz3EWze0qY2pz0NYMmqLeaVoFxcOEeG9WOYscbSoIOf51sa/f2l74Z1IWtzFMU hO7y3DY/Ks1RUZRUlfWz++xq8Q5xm4ytomvuuMTxU32FrqbTLmFPMjRA5A37+4+n9a0r3VFs9Rsb RomY3bMoYHhcDPNYniMFvCFiFbaxaABvQ8c1Xlsb6y8S6N9u1FrzfI+zcgXb8vNUqVOS5tt9NeiI derB8u/w66dWdlRRRXCekcz4h1Ca51SLRtMIS7lX99PjmKPqcH/Paq1k8UNtNBpUq2em2xxc37AF 5n7hf8fyq54uuPIghgtVUX9832dHA+YISN3P5Vl3t3aaVBcSOu7TNBjG2If8t7k9B7nJx9TXoQaV JO2n9a/ovmeXNN12r3f9afq310RqWstvBPCpidJJstGs7s88i/3iM/KPrXRKQVBHQ1wERnt55hdE SXwWKXUGz/rLiQ4htx6IuckDtj1NdPaauAvlnMjAlVI/iwxXP4sp/SuKc3J3PRp01BWRd1KJJbfE jlB0LBtpwevzdvwrBUQI0MVrCLxrf/j2tLZCsER/vMx4J9z+VXf7XW8kKxb2YIJQkRG9oz0dQeGH YjsRVC51S1KlLjX7iFO8SW/lyfTO3Nb0IX1S/P8ARf5HLialnZu33fq/8yrd+fbXE1tBILzX78bZ XT7ttH6D0H/666bQ9MTSNJhtY38zaMs+eCT1x7Vy0XnXML2nhyyezt5OJr65yGf8Tz/ntXWaRpw0 nTIbNZXlEY+8/wDnpWmJdoKN/l1/4HkjPCK9Ryt036fLvfqxNUm02wjXUdTkghS2yVmlONmeDg+9 UdP1jw9rcd1qNjd2lyI4ik8qtyqdSG7gVznjG1h1z4i+HNG1P59NMUtz5JPyzSKOAfXAHT3NaGoe EtB0ldU1DT7eO1vX06WMxQvsVl2nnYOD9a4uZ9zv5Yvoa1hpmgzW8Go2FvatFgSxToOMDuDUum32 jx6I1/p09uNNAeVpoz8nH3jn8DWR4GGfhhpY/wCnH+hrnfCrKPgJcZIAFndA+3L05TlLdijThH4U kdPqWo+ErTTorvUJ7FLS9fzo2c8SsR94DvwetNm1TwdpNoolutOt7fUIty/MNsyevuK4aPRdROn+ GNc06wtNY8jR0hl024Ybtp/jQHvzjNWvsPhrVPhJqd3p+mbGs4rgLHdDdJay9WVSegzg8U/aTta7 F7Kne/KvuOzPijwnfabITqdhLZ2hQud+VjOcJ+o4qS18S+GdbvUNrqNldXNsjSrsfJRQPmNcF4l0 fT9P+C1tcWVhbxT3MdmZmjQKZjkH5j35J/Otzw7ZOLLVp7vwbaaBLHaMscsRVmkBU7hkDjoKnmfc rlj2Oo07xfoGr3QttP1ezuJ2GRGkg3H6Ctmvnzw+1rq9p4X0nStDkttZS5WdtRZBGHjRiWIbqwxj 8q+g6RRVvo4BCbmaJHa3UyIzLkqQM8GvNJX+0xeFLCQ5/tPV2uph/fEfOD+OPyr1QgMCGAIPBBrh PGGmXjeOfCF1p9jJLb2s0nnGJPljVtoJPp3rRVLU3DuYuleqqnZP9Chp10Lq6sZ2ORf+Jp2Yn0jR wg/DYuKNMa4n0/ToonCXN1a3EUJJ6XME5kVT9fm/AGsBLx9O0G/fBMvh3xL9pkA6+U7EH88mtiaB 5NY1PQbSdYrmaYa5oVwT8rOeWT6E7uPRjWZsWZ7uzayTUJ0uY9IkkaRbq2J8/SLjP7xGxzsLZzxj OcjBFTpd+LZrcPoeveHtYgx8k0y7Hx/tbTjP5VmWWpXmq3Vzq3hbyrfWh8mr6DdHCzOvBZff379/ fnp38Ga1rkNjqnhnVdE1W5lERW3IVN7HHQ44yewoA6H/AIRHxP4wvdmv+K7VIrdld7TTWzsPVSRx jpxnPSvU1G1ACSSBjJ6mub8I+AtL8Ftctpr3DNchRJ5r5HGccY9zXTUAYHizwna+KrSBZJ5bS7tn 8y2uoTh4m749jWRo3w7SzlvbvU9XudT1O4t3tRcTH/UowwQoz71Z8YvqM15aR6bbPKbFTfud20Fl ICqP7xI3/L9KwYru8sLibFxcxrd3ryJG0P8Ax8CSUqQ7Y42pt29KANDQvh1faJcWRj8V6jLaWrKR akYjZR/DjPSoLr4Uo889tba9fWuiXU3my6ch+UknJUHsDUB1DW9K0yC1F1eM8YjeJ2iA3/ukYxn5 TnknA46HJ4qzPe62LkNJLLIsheZC9tuFuQZlG0AZ6BT3P50AaOveAlv7y0vtF1GfR761gFsskAyG iHRSPap7PwNa2Pgu88PxXUrfbVk8+6cZd3fqxFc6NT1ARvMb7UFeW3SJJeCuFkky4bZ0Pyjdtycj itfw9qOt3WqWk19JN5M+6N4WhCqmIUcN0yCWLD9O1AF3V/BcereCbfw6b2SJIUiUTqgLHZjBx74q rpHgjUNOuJnvPFGo6hFLA8PkzD5RuGN3XqK7CigDj1+H0UWh6HZQX8kd1o0vmQXYjG45JLKR6HPP 0rsKKKACiiigDlD8P7B9X16+eeYrrMPkywcbF4ALe7ZGQe2TXJWfgLxDfeDBZ3sqW+q6Nct/ZNyr YZkHYnspxx+FesUUAeYv4Dv/ABhodrrGpE6N4pQEGaDK78HClwOhOOo/+tXf2OmCPTbKHUCt5c28 aBp5VDMzgctk9881fooAKKKKACqdxpNldX8N7Pbq9xAMRuc8enHQ4zxnpVyigAooooAKKKKACiii gAooooA//9k= --_004_AS8PR01MB7704847246BA0B9843861408D4E09AS8PR01MB7704eurp_--